Literature DB >> 25298910

A Fatal Spontaneous Gas Gangrene due to Clostridium perfringens during Neutropenia of Allogeneic Stem Cell Transplantation: Case Report and Literature Review.

Hae-Lim Lee1, Sung-Yeon Cho1, Dong-Gun Lee2, Yumi Ko1, Ji In Hyun1, Bo Kyoung Kim1, Jae Hyun Seo1, Jung Woo Lee1, Seok Lee2.   

Abstract

Most cases of gas gangrene caused by Clostridium species begin with trauma-related injuries but in rare cases, spontaneous gas gangrene (SGG) can occur when patients have conditions such as advanced malignancy, diabetes, or immunosuppression. Clostridium perfringens, a rare cause of SGG, exists as normal flora of skin and intestines of human. Adequate antibiotics with surgical debridement of infected tissue is the only curative therapeutic management. Mortality rate among adults is reported range of 67-100% and majority of deaths are occurred within 24 hours of onset. We experienced a case of SGG on the trunk, buttock and thigh in a neutropenic patient with acute lymphoblastic leukemia. His clinical course was rapid and fatal during pre-engraftment neutropenic period of allogeneic stem cell transplantation.

Entities:  

Keywords:  Clostridium perfringens; Gas Gangrene; Neutropenia; Stem Cell Transplantation

Year:  2014        PMID: 25298910      PMCID: PMC4189134          DOI: 10.3947/ic.2014.46.3.199

Source DB:  PubMed          Journal:  Infect Chemother        ISSN: 1598-8112


Introduction

Gas gangrene, or clostridial myonecrosis, is one of the most serious infectious diseases, characterized by rapidly progressive destruction of soft tissue and production of gas within the tissues. It is usually caused by traumatic injury, however spontaneous gas gangrene (SGG) is rarely reported [1]. Recognized risk factors are gastrointestinal diseases, cancer chemotherapy, lympho-proliferative disorders, radiation therapy, acquired immunodeficiency syndrome (AIDS) and neutropenic state [1]. The anaerobic gram-positive bacillus Clostridium perfringens, one of the causative pathogens of gas gangrene, is normal flora of skin or intestines. In SGG, source of the infection is usually the bowel [1]. We experienced a case of fatal SGG in patient with acute lymphoblastic leukemia (ALL) during pre-engraftment period of allogeneic stem cell transplantation (SCT). The Institutional Review Board at Seoul St. Mary's Hospital approved this case report and exempted patient consent (No. KC13ZISE0088).

Case Report

A 57-year-old male was admitted for unrelated peripheral blood SCT in June 2012. He was diagnosed as Philadelphia-positive ALL in January 2012 and treated with remission-induction chemotherapy and five cycles of intra-thecal chemotherapy. He had no other underlying disease. On hospital day (HD) 1, initial vital signs were stable as follows: blood pressure 110/60 mmHg, pulse rate 80/min, respiratory rate 20/min, and body temperature 36.4℃. On HD 5, pre-transplant conditioning chemotherapy was started with fludarabine (30 mg/m2) for 5 days, melphalan (70 mg/m2) for 2 days and anti-thymocyte immunoglobulin (1.25 g/kg) for 2 days. Ciprofloxacin (500 mg po bid), itraconazole syrup (150 mg po bid) and acyclovir (5 mg/kg iv tid) were used as prophylaxis. From HD 13 to 14 (also represented as post SCT D1 to D2), SCT was done and neutropenia developed (absolute neutrophil count [ANC] 890/mm3), and progressed after that day. He started to feel intermittent mild abdominal pain and diarrhea (3-4 times/day) from post SCT D4. Additional antibiotics for diarrhea was not prescribed because the patient's symptom was mild and controlled easily with medications other than antibiotics. And there were neither infection signs including fever nor increase of C-reactive protein. The patient also had suffered from chronic diarrhea before hospitalization and C. difficile toxin assay and culture done at HD 5 revealed negative results. On the morning of post SCT D7, he complained of severe pain at the left chest wall, left buttock and thigh with localized swelling, and the tissue edema was progressed rapidly. We examined the patient's body thoroughly, however we could not find any obvious traumatic injury. He had an intravenous Hickman catheter and there was no infectious signs at the exit site. Although he had no other signs of infection, we immediately started empirical antibiotics with piperacillin/tazobactam (4/0.5 g iv q8hr) and vancomycin (1 g iv q12hr). At that time, a complete blood cell count revealed hemoglobin of 9.3 g/dL, hematocrit of 25.2%, white blood cells of 10/mm3 (ANC 0/mm3) and platelet 61,000/mm3. Ciprofloxacin which had been used as prophylactic antibiotics was stopped. Chest X-ray showed soft tissue swelling with air density on the left side of chest wall (Fig. 1). The patient's blood pressure began to fall to 92/60 mmHg, heart rate was 164/min and oxygen saturation was 83% at the room air. We pushed 500 mL of normal saline and applied 5 L of oxygen via a simple facial mask. After that, his vital signs stabilized again. Chest and abdominal computed tomography revealed multiple emphysematous soft tissue infection of left lateral chest wall, back, left buttock and thigh area (Fig. 2). After identification of the lesions, the needle aspiration was done from the soft tissue lesion to identify the causative organism in sterile environment. Ten hours after onset of pain, heart rate increased to 163/min despite blood pressure was not changed with 98/63 mmHg. He was planned to be transferred to intensive care unit to manage his sepsis. Cardiac arrest was occurred after approximately 12 hours from his first complaint of pain on those lesions. Cardiopulmonary resuscitation was done for over 30 minutes but he died without return of spontaneous circulation. Later, Clostridium perfringens was isolated from both blood cultures and culture of aspirated fluid from the lesion (BD BACTEC™ Plus Aerobic/F, Lytic/10 Anaerobic/F Culture Vials, Becton Dickinson, Sparks, MD, USA).
Figure 1

Chest X-ray shows soft tissue swelling on the left chest wall with internal air density.

Figure 2

Computed tomography of chest and abdomen. Subcutaneous emphysema on (A) the left chest wall (arrow) and (B) left trunk (arrow).

Discussion

The proportion of anaerobic bacteremia was 0.5-12% depending on researchers [2] and Clostridia are the second common anaerobes (20.7%) following Bacteroides fragilis group (36.7%) [3, 4]. Park et al. [2] reported recent trends of anaerobic bacteria isolated from blood culture specimens in a university hospital of Korea. Of the 84 anaerobic isolates, B. fragilis (28.6%, 24 of 84 isolates) and C. perfringens (25%, 21 of 84 isolates) were the most frequently isolated organisms [2]. C. perfringens was not a rare causative organism of anaerobic bacteremia. However, the clinical significance of C. perfringens is not yet fully understood. C. perfringens is a spore-forming gram positive rod that causes disease by toxin production and regional tissue destruction [3, 5]. It can cause wide range of diseases from a self-limited gastroenteritis to a life-threatening gas gangrene [3, 5]. We found 7 case reports of human diseases caused by C. perfringens from Koreamed (www.koreamed.org); they were about emphysematous hepatitis, massive intravascular hemolysis associated with sepsis, pseudomembranous colitis and endocarditis as well as more common food poisoning and diarrhea. To the best of our knowledge, this is the first case of SGG with bacteremia caused by C. perfringens in Korea. We did a literature review to find case reports of SGG of which the pathogen was C. perfringens. Three reports were found and these are described in Table 1 including this case [6, 7, 8]. All of the cases in the table had one or more risk factors of clostridial SGG such as diabetes, atherosclerosis, malignancies or immunosuppression. Of the 5 SGG patients, four had underlying hematological malignancies.
Table 1

Summary of spontaneous gas gangrene cases caused by Clostridium perfringens (including this case)

We suppose that the portal of entries of C. perfringens in SGG might be gastrointestinal tract. Because C. perfringens is normal flora of skin and gastrointestinal tract of human and none of the 5 patients listed in Table 1 had no identifiable skin injury. In this case, the patient had suffered from chronic diarrhea that was aggravated over time after admission. Therefore, infection caused by C. perfringens might be started from the gastrointestinal tract, and spread rapidly to the bloodstream through possible mucosal breaks of intestine. And this process could be accelerated by the patient's immunocompromised state related to lymphoblastic leukemia. We suppose that underlying diseases of cases listed on Table 1 might be one of the causes of damaged gastrointestinal tract. Initial symptoms include fever and/or pain at specific areas of body such as calf, thigh and chest wall. Crepitus or gas formation identified from imaging had been a clue for suspecting SGG that enabled more aggressive surgical management. Four patients died despite the administration of proper antibiotics and concurrent surgical debridement (Table 1). Surgical debridement is the mainstay of therapy in SGG because necrotic tissues are poorly perfused due to vascular thrombosis, which made tissue concentration of antibiotics suboptimal. Prompt surgical management is the key factor for survival. Although limited effect of antibiotics in gas gangrene, its early application is emphasized because bacteremia might be preceded to gas gangrene. Initially, the broad spectrum antibiotics are desirable until the pathogen is identified in laboratory. When clostridial infection is identified, penicillin (3-4 million units iv q 4 hours) and clindamycin (600-900 mg or 15 mg/kg iv q 8 hours) is a drug of choice [5, 9] and it is suggested that tetracycline, erythromycin, rifampin, chloramphenicol and metronidazole were more efficacious than penicillin in experimental myonecrosis models [5]. In this case, our empirical choice of antibiotics was piperacillin/tazobactam and vancomycin which have broad-spectrum coverage in neutropenic patients and known to be susceptible in Clostridium species [5]. Although we could not perform surgical intervention because of rapid and fatal clinical course, aggressive surgical debridement is an important part in management of SGG. SGG shows higher mortality than traumatic gas gangrene because of two important reasons. First, when compared with traumatic gas gangrene, diagnosis is often delayed in SGG. Crepitus on physical examination or identifiable gas from imaging might be clues to suspect the diagnosis but they are late manifestation during the clinical course of SGG. When physicians can recognize SGG, patients already have bacteremia and often progressed to severe sepsis accompanying multiorgan failure. And the other reason is that the patients with SGG usually have other serious comorbidities which make difficulties in coping with his fatal condition. In this case, the patient was in prolonged neutropenia which made it difficult to do procedures or surgical management. In conclusion, patients with hematological diseases, especially in neutropenic state after SCT, can encounter various infectious diseases and its complications. As in this case, SGG caused by C. perfringens can be developed in patients with predisposing factors and resulted in fatal outcome. We emphasize here that if patient complains about soft tissue swelling and pain with predisposing factors of SGG such as diabetes, atherosclerosis, malignancies or immunosuppression, SGG can be a disease as a high priority even in cases without trauma history. And if the patient has symptoms of gastrointestinal tract, that also makes high index of suspicion to clostridial infection because gastrointestinal tract can be a portal of entry in most cases.
  6 in total

1.  Is the incidence of anaerobic bacteremia decreasing? Analysis of 114,000 blood cultures over a ten-year period.

Authors:  Lukas Fenner; Andreas F Widmer; Clarisse Straub; Reno Frei
Journal:  J Clin Microbiol       Date:  2008-05-07       Impact factor: 5.948

Review 2.  Life-threatening clostridial infections.

Authors:  Dennis L Stevens; Michael J Aldape; Amy E Bryant
Journal:  Anaerobe       Date:  2011-11-20       Impact factor: 3.331

3.  Clostridial myonecrosis: new insights in pathogenesis and management.

Authors:  Amy E Bryant; Dennis L Stevens
Journal:  Curr Infect Dis Rep       Date:  2010-09       Impact factor: 3.725

4.  Gas gangrene in patient with atherosclerosis obliterans.

Authors:  Masanori Niimi; Yosifumi Ikeda; Shigenao Kan; Hiroshi Takami
Journal:  Asian Cardiovasc Thorac Ann       Date:  2002-06

Review 5.  Gas gangrene secondary to Clostridium perfringens in pediatric oncology patients.

Authors:  Ana-Maria M Temple; Neal J Thomas
Journal:  Pediatr Emerg Care       Date:  2004-07       Impact factor: 1.454

Review 6.  Spontaneous gas gangrene in malignant lymphoma: an underreported complication?

Authors:  Julio García-Suárez; Dunia de Miguel; Isabel Krsnik; Mohammed Barr-Alí; Nuria Hernanz; Carmen Burgaleta
Journal:  Am J Hematol       Date:  2002-06       Impact factor: 10.047

  6 in total
  5 in total

Review 1.  The Exosporium Layer of Bacterial Spores: a Connection to the Environment and the Infected Host.

Authors:  George C Stewart
Journal:  Microbiol Mol Biol Rev       Date:  2015-12       Impact factor: 11.056

2.  Septic Shock and Spontaneous Gangrenous Gas Necrosis of the Spleen Secondary to Clostridium perfringens: The Importance of Source Control.

Authors:  Morgan Oskutis; Matthew Reaven
Journal:  Case Rep Crit Care       Date:  2021-05-06

3.  Acute Hemolysis with Renal Failure due to Clostridium Bacteremia in a Patient with AML.

Authors:  R M Medrano-Juarez; D Sotello; M A Orellana-Barrios; L D'Cuhna; J D Payne; K Nugent
Journal:  Case Rep Infect Dis       Date:  2016-09-27

Review 4.  Vaccine Production to Protect Animals Against Pathogenic Clostridia.

Authors:  Nicolas E Zaragoza; Camila A Orellana; Glenn A Moonen; George Moutafis; Esteban Marcellin
Journal:  Toxins (Basel)       Date:  2019-09-11       Impact factor: 4.546

5.  Gangrenous gas necrosis of the spleen: a case report.

Authors:  Jeremy Meyer; Arnaud Dupuis; Benedikt D Huttner; Matthieu Tihy; Léo Bühler
Journal:  BMC Infect Dis       Date:  2019-09-05       Impact factor: 3.090

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.